Why Researchers at the Nobel Prize Institute Are Studying This Molecule After 50

If you're over 50 and following cardiovascular research, you may have noticed something unusual happening in Sweden. At the Karolinska Institute — the same institution that selects the Nobel Prize laureates in Physiology or Medicine each year — researchers have spent the past two decades quietly building a body of work around a single molecule. A molecule most Americans have never heard of, despite the fact that its discovery won the Nobel Prize in 1998.

That molecule is nitric oxide. And according to a peer-reviewed study published in Nutrients in November 2024, supporting your body's nitric oxide production may matter more after 50 than at any other point in life.

The study — conducted at the Karolinska Institute in Stockholm in collaboration with researchers from Uppsala University — is part of a larger scientific question that has fascinated Nordic researchers for years: What if the molecule that earned the Nobel Prize could also help protect the body as it ages?

The 1998 Discovery That Most Americans Missed

In October 1998, the Nobel Assembly at the Karolinska Institute awarded the Nobel Prize in Physiology or Medicine to three American scientists — Robert F. Furchgott, Louis J. Ignarro, and Ferid Murad — for what the committee called "their discoveries concerning nitric oxide as a signalling molecule in the cardiovascular system."

The discovery was, in scientific terms, seismic. Nitric oxide turned out to be the molecule your body uses to tell your blood vessels to relax and widen. When endothelial cells lining your arteries release nitric oxide, blood flows more freely. Pressure normalizes. Oxygen and nutrients reach tissues efficiently.

But there was a catch the press largely missed: nitric oxide production declines with age. Research published in the years following the Nobel Prize has consistently shown that healthy adults in their 60s and 70s produce significantly less nitric oxide than they did in their 30s. The vascular system, in other words, slowly loses one of its most important signaling tools.

What Karolinska Researchers Set Out to Study

The 2024 study, led by researchers in the Department of Physiology and Pharmacology at the Karolinska Institute, asked a deceptively simple question: Could a food supplement built around the nitric oxide pathway help protect cardiovascular, kidney, and metabolic function in a model of accelerated aging?

The formulation they tested combined four ingredients with well-documented roles in nitric oxide biology:

— Beetroot extract, a dietary source of nitrate that the body converts into nitric oxide through a pathway independent of the enzymes that decline with age.
— L-citrulline, an amino acid that supports the body's endogenous nitric oxide synthesis.
— L-arginine, the direct substrate from which nitric oxide is produced.
— Rhodiola rosea extract, a Nordic adaptogenic herb traditionally used to support vitality.

That formula is what BioConcept AB, a small Swedish life sciences company, calls Flexovital N.O.RDIC. The "N.O." is not a coincidence — it is the chemical symbol for nitric oxide.

What the Researchers Found

The findings, published in November 2024, are striking — though the researchers themselves are careful to emphasize that this was a preclinical study, not a human trial. The animal model was designed to mimic the cardiovascular-kidney-metabolic stress that often accompanies aging in humans: a high-salt, high-sugar, high-fat Western diet combined with reduced kidney capacity.

Over 12 weeks, the group receiving the Flexovital formula showed measurable differences from the untreated group across several markers:

Perhaps most interesting to the researchers was what happened at the cellular level. Mitochondria — the energy producers inside every cell — showed improved efficiency in the Flexovital group. Endothelial function, the very ability of blood vessels to relax in response to chemical signals, was significantly restored.

In other words: the molecule that won the Nobel Prize in 1998 may also be one of the keys to supporting cardiovascular and metabolic health as the body ages.

Why This Matters After 50

For Americans over 50, the implications are worth thinking about carefully — and with appropriate skepticism. This was a preclinical study. Human trials are planned but not yet completed. Flexovital is a dietary supplement, not a medication.

What the research does suggest is that supporting your body's nitric oxide production is a reasonable thing to think about as you age — and that the science behind it is not fringe wellness marketing. It is Nobel-Prize-winning biology, being actively researched at one of the world's most respected medical institutions.

The body has two main pathways to produce nitric oxide. The first, called the L-arginine pathway, depends on enzymes that gradually become less efficient with age. The second, called the nitrate-nitrite pathway, can be supported through dietary nitrate — naturally found in beetroot and certain leafy greens.

That second pathway is part of why beetroot has received serious scientific attention in cardiovascular research over the past decade. It offers what researchers call a "redundant system" — a backup route to nitric oxide that doesn't depend on enzymes that decline.

What's Next

The Karolinska researchers have indicated that human clinical trials are planned for 2025 to further investigate nitric oxide's role in circulation and vitality. Until those results are available, Flexovital remains in the category most informed consumers use it as: a research-backed daily supplement that supports the body's own nitric oxide systems, taken alongside the obvious foundations of cardiovascular health — exercise, sleep, diet, and routine check-ups with your doctor.

What makes the Swedish work distinctive is not a marketing claim. It is the institutional context. When researchers at the Karolinska Institute publish a peer-reviewed paper in Nutrients, it carries a different weight than the typical American supplement story. Whether that weight will translate into something meaningful for human health is a question the next round of research will help answer.

For now, the formula they studied is available to American consumers for the first time — shipped directly from Sweden, with duties and taxes included in the price.